Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP)

INTRODUCTION: Post-marketing surveillance activities (namely pharmacovigilance) are crucial to favor the early detection of unexpected adverse events (AEs) and/or serious adverse reactions (SAEs). Indeed, spontaneous reporting of AEs has been demonstrated to underestimate the number of events in dif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Palleria, Caterina, Iannone, Luigi, Leporini, Christian, Citraro, Rita, Manti, Antonia, Caminiti, Maurizio, Gigliotti, Pietro, Grembiale, Rosa Daniela, L’Andolina, Massimo, Muccari, Giuseppe, Naturale, Maria Diana, Olivo, Domenico, Pagano Mariano, Giuseppa, Pellegrini, Roberta, Varcasia, Giuseppe, Abdalla, Karim, Russo, Emilio, Ursini, Francesco, De Sarro, Giovambattista
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200211/
https://ncbi.nlm.nih.gov/pubmed/30356301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205134
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars